Sabby Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Sabby Management, LLC

  • $9.65 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018
SELL
$88.31 - $107.8 $1.02 Million - $1.24 Million
-11,500 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$115.92 - $148.54 $898,380 - $1.15 Million
-7,750 Reduced 40.26%
11,500 $1.37 Million
Q4 2017

Feb 14, 2018
BUY
$114.49 - $139.98 $2.2 Million - $2.69 Million
19,250
19,250 $2.45 Million

Others Institutions Holding ALNY

# of Institutions
675
Shares Held
108M
Call Options Held
839K
Put Options Held
771K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.5B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Sabby Management, LLC Portfolio

Follow Sabby Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sabby Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email